Samuel Straface thought he was the last one out the door one recent evening at the medical-technology startup he leads in suburban Boston.
But as he passed a glass-walled conference room on the second floor, Dr. Straface says he saw a man he didn’t recognize, sitting by himself in front of two open laptops and a tablet device. He continued walking a few steps toward the exit, but then, feeling uneasy, he turned back.
The man was later identified as Dong Liu, a dual citizen of China and Canada. And his after-hours computing at Medrobotics Corp. is at the center of an economic-espionage case brought by U.S. prosecutors.
You've reached your daily free article limit.
Subscribe and support our veteran writing staff to continue reading.
Samuel Straface thought he was the last one out the door one recent evening at the medical-technology startup he leads in suburban Boston.
But as he passed a glass-walled conference room on the second floor, Dr. Straface says he saw a man he didn’t recognize, sitting by himself in front of two open laptops and a tablet device. He continued walking a few steps toward the exit, but then, feeling uneasy, he turned back.
The man was later identified as Dong Liu, a dual citizen of China and Canada. And his after-hours computing at Medrobotics Corp. is at the center of an economic-espionage case brought by U.S. prosecutors.
Mr. Liu is in federal custody, charged with attempting to steal trade secrets and trying to gain unauthorized access to the company’s computer system, prosecutors said. If convicted of both charges, he could face a maximum sentence of 15 years in prison.
“Mr. Liu adamantly asserts his innocence and we fully expect he’ll be exonerated after a careful review of the evidence,” said Robert Goldstein, Mr. Liu’s defense attorney. The U.S. attorney’s office for the District of Massachusetts declined to comment on the case beyond details in court records.
Read the whole story from The Wall Street Journal.
Featured image courtesy of Wikimedia Commons
Join SOFREP for insider access and analysis.
TRY 14 DAYS FREEAlready a subscriber? Log In
COMMENTS
You must become a subscriber or login to view or post comments on this article.